Drug Name Fluorouracil (i.v.) and capecitabine Drug Class Anticancer Risk minimization type Direct Healthcare Professional Communication DHPC Specialty (Theraputic area) Oncology Risk risk of severe toxicity Dear Healthcare provider letter DHPC